BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32859709)

  • 21. Prognostic value of [
    Takenaka J; Watanabe S; Abe T; Hirata K; Uchiyama Y; Kimura R; Shinohara N; Kudo K
    Ann Nucl Med; 2023 Jan; 37(1):10-17. PubMed ID: 36301465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model.
    Gaertner FC; Wiedemann T; Yousefi BH; Lee M; Repokis I; Higuchi T; Nekolla SG; Yu M; Robinson S; Schwaiger M; Pellegata NS
    J Nucl Med; 2013 Dec; 54(12):2111-7. PubMed ID: 24136933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenal tracer uptake by
    Noordzij W; Glaudemans AWJM; Schaafsma M; van der Horst-Schrivers ANA; Slart RHJA; van Beek AP; Kerstens MN
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1560-1566. PubMed ID: 31011769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging of pheochromocytoma and paraganglioma.
    Brink I; Hoegerle S; Klisch J; Bley TA
    Fam Cancer; 2005; 4(1):61-8. PubMed ID: 15883712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic status determines
    Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma.
    Maurice JB; Troke R; Win Z; Ramachandran R; Al-Nahhas A; Naji M; Dhillo W; Meeran K; Goldstone AP; Martin NM; Todd JF; Palazzo F; Tan T
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1266-70. PubMed ID: 22526961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Significance of Quantitative 123I-MIBG SPECT/CT Analysis of Pheochromocytoma and Paraganglioma.
    Nakamoto R; Nakamoto Y; Ishimori T; Togashi K
    Clin Nucl Med; 2016 Nov; 41(11):e465-e472. PubMed ID: 27607159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Same-day comparative protocol PET/CT-PET/MRI [
    Prado-Wohlwend S; Ballesta-Moratalla M; Torres-Espallardo I; Del Olmo-García MI; Bello-Arques P; Olivas-Arroyo C; Merino-Torres JF
    Cancer Imaging; 2023 Jan; 23(1):4. PubMed ID: 36627700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superiority of
    Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of 68Ga-DOTA-Octreotate PET/CT in Follow-Up of SDH-Associated Pheochromocytoma and Paraganglioma.
    Kong G; Schenberg T; Yates CJ; Trainer A; Sachithanandan N; Iravani A; Ravi Kumar A; Hofman MS; Akhurst T; Michael M; Hicks RJ
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5091-5099. PubMed ID: 30977831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
    Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging.
    Havekes B; Lai EW; Corssmit EP; Romijn JA; Timmers HJ; Pacak K
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):419-29. PubMed ID: 19088695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery.
    Nockel P; El Lakis M; Gaitanidis A; Merkel R; Patel D; Nilubol N; Prodanov T; Pacak K; Kebebew E
    Ann Surg; 2019 Apr; 269(4):741-747. PubMed ID: 29334561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas.
    Moreau A; Giraudet AL; Kryza D; Borson-Chazot F; Bournaud C; Mognetti T; Lifante JC; Combemale P; Giammarile F; Houzard C
    Nucl Med Commun; 2017 Sep; 38(9):771-779. PubMed ID: 28704339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Performance of
    Weber M; Schmitz J; Maric I; Pabst K; Umutlu L; Walz M; Herrmann K; Rischpler C; Weber F; Jentzen W; Theurer S; Poeppel TD; Unger N; Fendler WP
    J Nucl Med; 2022 Jun; 63(6):869-874. PubMed ID: 34556526
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnostic accuracy of (68)Ga-DOTANOC PET/CT imaging in pheochromocytoma.
    Sharma P; Dhull VS; Arora S; Gupta P; Kumar R; Durgapal P; Malhotra A; Chumber S; Ammini AC; Kumar R; Bal C
    Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):494-504. PubMed ID: 24158184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.
    Kaji P; Carrasquillo JA; Linehan WM; Chen CC; Eisenhofer G; Pinto PA; Lai EW; Pacak K
    Eur J Endocrinol; 2007 Apr; 156(4):483-7. PubMed ID: 17389464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of
    Han S; Suh CH; Woo S; Kim YJ; Lee JJ
    J Nucl Med; 2019 Mar; 60(3):369-376. PubMed ID: 30030341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
    Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Ling A; Eisenhofer G; Adams KT; Solis D; Lenders JW; Pacak K
    J Clin Oncol; 2007 Jun; 25(16):2262-9. PubMed ID: 17538171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.